Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 2 Feb 2005 |
| Novozymes, annual report 2004 - No. 3 Regnskab og data CD - UK | 2 Feb 2005 |
| Novozymes, annual report 2004 - No 6 GRI Indicators UK | 2 Feb 2005 |
| Novozymes, preliminary announcement of annual report 2005 | 31 Jan 2005 |
| Novozymes, own shares (section 28) | 4 Jan 2005 |